MRI Muscle in Trauma and Mechanical Disorders — Generic Standard Protocol

(designed for non-specific, atraumatic or traumatic pain, sport-related or not, with or without general movement limitation, or suspected osteoarticular disease)

MRIninja Knowledge Base | Master / General Protocol Page Anatomical domain: peripheral skeletal muscle (limbs, girdle, and trunk musculature) Version 1.0 — July 2026

1. Executive Summary

Magnetic resonance imaging is the reference-standard modality for the non-invasive assessment of skeletal muscle in trauma and mechanical/overuse disorders. Its combination of high soft-tissue contrast, multiplanar capability, and sensitivity to interstitial oedema allows direct visualisation of the myotendinous, myofascial and myoaponeurotic junctions — the structurally weakest points of the muscle-tendon unit and the site of the majority of indirect (strain-type) injuries MR imaging of muscle trauma covers anatomy, biomechanics, pathophysiology, and imaging appearance and is the modality of choice for evaluating the connective tissue components of muscle injury. Compared with ultrasound, MRI is less operator-dependent, provides a panoramic and reproducible field of view, and characterises deep muscle compartments that are difficult to insonate; compared with CT, it avoids ionising radiation and offers markedly superior soft-tissue contrast. Radiography and CT remain relevant only to exclude an osseous avulsion, apophyseal injury, heterotopic ossification or radio-opaque foreign body, and are not substitutes for MRI in the assessment of the muscle belly itself.

This generic protocol is designed to answer the broad clinical question “is there a muscle/tendon/fascial injury, and how extensive is it?” for the everyday spectrum of muscular complaints: muscle strain, partial and complete muscle tears, contusion, delayed-onset muscle soreness (DOMS), chronic scarring from prior injury, myotendinous-junction injuries, exercise-related pain, and non-specific muscular pain without a clear traumatic mechanism.

The generic protocol is intentionally broad and is not designed to: - provide elite-athlete-level prognostic grading of hamstring re-injury risk (which benefits from dedicated, standardised acquisition protocols used in sports-medicine cohorts); - characterise a suspected soft-tissue neoplasm (a distinct, dedicated whole-body/loco-regional oncological protocol is required, following ESSR soft-tissue tumour imaging guidance); - evaluate suspected myopathy, myositis, rhabdomyolysis or a hereditary muscular dystrophy, which require dedicated inflammatory/T2-mapping or whole-body protocols; - resolve compartment syndrome, which is a clinical–pressure diagnosis and not an MRI indication in the acute emergency setting.

When any of the above is suspected, this master page should route to the relevant dedicated child protocol; the generic muscle-trauma protocol should not be stretched to cover these indications.

1.1 Core strengths

• Direct depiction of the myoconnective junction (myotendinous, myofascial, myoaponeurotic) and quantification of interstitial oedema, fibre discontinuity and haematoma, which are the substrate of all current MRI-based grading systems a protocolized approach to the evaluation of MRI findings is essential to accurately assess the severity of acute lesions and to evaluate the progression of reparative changes.
• Multiplanar, high-resolution assessment feasible at both 1.5 T and 3 T with surface coils and a limited field of view tailored to the region of clinical concern.
• Excellent longitudinal reproducibility for serial follow-up of healing, re-injury, and rehabilitation load management.
• Ability to differentiate structural (fibre/tendon disruption) from purely functional/oedema-only muscle disorders, which carry markedly different management pathways and return-to-activity timelines.

1.2 Intrinsic limitations of the generic protocol

A generic protocol is a compromise between anatomical coverage, acquisition time, and diagnostic specificity. Because most muscle groups (hamstrings, quadriceps, adductors, triceps surae) have complex, muscle-specific connective-tissue architecture, a truly optimised examination is often planned around the specific muscle compartment indicated by clinical examination, not the entire limb. The core limitations of the generic protocol are:

• Field-of-view trade-off: a limited FOV centred on the palpable/marked site of pain maximises spatial resolution but may under-sample an adjacent or non-contiguous second lesion; a whole-limb overview sacrifices resolution.
• Timing dependence: MRI signal does not evolve significantly in the first week after acute injury, but a scan performed too early after a non-acute or overuse presentation may under-represent chronic change, and a scan performed months after resolution of symptoms may show a falsely reassuring or, conversely, a persistently abnormal signal that no longer reflects clinical status.
• Limited prognostic specificity: none of the three widely used classification systems (Munich Consensus, BAMIC, FC Barcelona-Aspetar-Duke) has been shown to reliably predict return-to-play time in isolation from clinical factors; MRI findings, taken alone, correlate imperfectly with recovery time.
• DOMS/overuse mimicry: diffuse, non-specific (“cotton-like”) oedema of overuse or DOMS can overlap in appearance with mild structural injury or with early inflammatory/infective myopathy, and requires clinical correlation.
• Contrast is essentially unnecessary for routine indirect/direct muscle trauma; its use is reserved for excluding a co-existing mass-like lesion, abscess, or for problem-solving atypical presentations (see Section 6).

2. Main Clinical Indications

2.1 Standard Indications

The generic protocol is appropriate for the broad majority of muscular complaints referred for MRI, including: acute muscle strain following sprinting, kicking, jumping or eccentric loading; suspected partial or complete muscle tear; blunt contusion; chronic or recurrent muscle pain with prior injury history; suspected myotendinous-junction injury; non-specific exertional muscle pain not explained by clinical examination; and clinical suspicion of DOMS that has not resolved as expected. In all of these scenarios the generic protocol is usually sufficient as a first-line study, because the diagnostic question — presence, site, and extent of oedema/fibre disruption — is answered by the same core sequence set regardless of the specific muscle group. A dedicated protocol becomes necessary when the clinical question moves beyond simple grading: pre-operative planning for a complete tendinous avulsion requiring surgical repair (e.g., proximal hamstring avulsion), suspected concomitant neural injury (sciatic nerve involvement in high hamstring injuries), suspected osseous apophyseal avulsion in a skeletally immature patient, or when a mass-like, non-oedematous lesion raises concern for a soft-tissue tumour rather than a traumatic injury.

2.2 Urgent Red Flags Requiring Expedited or Emergency Imaging

Peripheral skeletal muscle disease is very rarely immediately life- or limb-threatening, and this generic protocol should not be over-weighted with emergency-oriented content; however, a small number of presentations warrant expedited imaging or same-day clinical referral rather than routine outpatient scheduling.

3. Preparation Reference

Universal MRI safety screening (implants, devices, claustrophobia, contrast safety questionnaire) belongs to the general MRI preparation page and is not repeated here.

3.1 Anatomy-Specific Preparation Items

• Skin marker at the point of maximum tenderness: essential. The referring clinician’s or the patient’s indication of the symptomatic site should be marked with a skin-visible marker before planning, since this is the single most effective way to ensure the correct region and an adequately small field of view are selected, particularly for adductor, calf and proximal hamstring pain where symptoms may be diffuse or referred.
• History of recent exercise: patients should be asked about strenuous activity in the preceding 24–48 hours, since post-exercise physiological change and DOMS can produce diffuse T2/STIR hyperintensity that mimics or masks a structural injury; this history should be documented on the request form and in the report.
• Prior injury/surgery in the same region: important for correct interpretation, since chronic scar tissue, fatty atrophy, and post-surgical anchors or hardware alter the baseline appearance and can be mistaken for new injury if the history is not known.
• Compression garments/bandaging: should be removed for coil placement when possible; note in the report if unremovable dressings degrade coil contact or introduce artefact.
• Metal near the region: orthopaedic hardware from prior surgery (screws, plates, intramedullary devices) close to the muscle compartment of interest should be documented, as this dictates the choice between spectral fat saturation and STIR/Dixon (see 4.5) and the need for metal-artefact-reduction sequences.
• Coil selection: flexible surface coils/phased-array coils conforming to the limb contour are preferred over the built-in body coil whenever anatomically feasible, since they materially improve signal-to-noise ratio and permit the thin-slice, small-FOV acquisitions required for accurate lesion measurement.

3.2 Patient Positioning on the MRI System

• Position: supine for virtually all lower-limb muscle groups (hamstrings, quadriceps, adductors, calf); prone positioning may be used selectively for posterior thigh/hamstring imaging in some departments to reduce motion and improve comfort, but supine is the standard and more reproducible default.
• Limb orientation: neutral rotation whenever possible; slight external rotation of the leg is common for adductor imaging and should be documented and reproduced on follow-up studies, since rotation changes the apparent orientation of the myoaponeurotic planes.
• Centring: the marked skin site of symptoms should be centred within the coil and within the field of view; for bilateral or comparative studies (e.g., suspected chronic bilateral hamstring pain), consider whether a wider FOV including both limbs, at reduced resolution, is clinically preferable to two separate limited-FOV studies.
• Immobilisation: foam padding and, where available, dedicated limb supports/straps to minimise voluntary and involuntary motion; for calf and ankle imaging, foot dorsi/plantarflexion should be standardised and documented, since positioning changes both muscle length and apparent fibre orientation.
• Comfort strategies: allow analgesia to take effect before scanning in acutely painful contusions/tears; excessive scan-table time in a painful position increases motion artefact and reduces diagnostic yield disproportionately in this group of patients.
• Common positioning errors: failure to mark the symptomatic site before planning (leading to an incorrectly centred FOV); asymmetric limb rotation between sides in comparative studies; scanning through compressive dressings that displace the coil from the skin surface.
• Practical technologist checks before starting: confirm laterality on the request matches the marked/marked-and-verbally-confirmed side; confirm the coil is centred over the marked point; confirm FOV includes the full craniocaudal extent of the muscle belly of clinical concern, not only the point of maximal tenderness.

4. Standard Protocol Design

4.1 Mandatory Core Sequences

4.2 Conditional Sequences

4.3 Rationale Summary Per Sequence

Fluid-sensitive fat-suppressed sequences (FS T2 or intermediate-weighted, STIR) are the diagnostic backbone of muscle-trauma MRI. They depict interstitial oedema, haemorrhage, and the “feathery” pattern of fibre disruption at the myoconnective junction with high conspicuity against a homogeneously suppressed fat background the identification of edematous changes around the myotendinous, myoaponeurotic, and myofascial junctions ensures an accurate connective tissue assessment, as well as allowing the delineation of intramuscular or intermuscular fluid collections or hematomas. An intermediate echo time (below roughly 65 ms) is preferred over a very long TE, since it balances fluid conspicuity with retained anatomical/connective-tissue detail. The principal pitfall is over-calling the extent of injury: oedema frequently “tracks” along fascial planes well beyond the actual site of fibre disruption, and grading systems that rely purely on oedema extent (rather than fibre/tendon discontinuity) can therefore over-estimate severity.

T1-weighted non-fat-suppressed sequences provide the anatomical roadmap (fascicular architecture, fat planes, vascular landmarks) and are essential for dating haemorrhage (subacute blood is characteristically T1-hyperintense), for detecting fatty atrophy and chronic scarring from prior injury, and for excluding an unsuspected fat-containing or haemorrhagic mass. T1 is comparatively insensitive to acute oedema and must never be used as a substitute for the fluid-sensitive sequence when grading acute injury.

STIR offers robust, field-inhomogeneity-independent fat suppression and is the preferred fallback whenever spectral fat saturation is technically unreliable — for example, in curved limb contours, at the periphery of a large FOV, or in patients with hardware nearby — consistent with the broader project principle that STIR, rather than SPAIR, should be favoured for off-isocentre or field-inhomogeneous applications. Its main limitation is a lower signal-to-noise ratio and longer acquisition time relative to spectral techniques at comparable resolution.

Diffusion-weighted imaging is not yet part of the routine mandatory protocol but has documented utility as a problem-solving adjunct: apparent diffusion coefficient values differ between simple oedema, haematoma, and more solid/cellular collections, which can help discriminate a resolving haematoma from an abscess or from a soft-tissue mass in equivocal cases Nocerino EA, Aliprandi A, Tavana, Mazzoni S, Di Leo G, Genovese EA. Evaluation of muscle tears in professional athletes using diffusion-weighted imaging and apparent diffusion coefficient: preliminary results represents an evolving evidence base rather than an established standard.

4.4 Sequence Matching and Cross-Sequence Consistency

Matching geometry (identical slice thickness, gap, FOV and angulation) between the T1 and fluid-sensitive sequences in each plane is important so that a T1-bright focus (subacute blood, fat) and a T2/STIR-bright focus (oedema, fluid) can be confidently attributed to the same anatomical location. Pre/post-contrast matching and subtraction are relevant only in the uncommon subset of examinations where contrast is used to exclude an abscess or mass (Section 6); for routine trauma imaging, subtraction is not required. Exact slice-for-slice matching can reasonably be relaxed for coronal/sagittal overview planes acquired mainly for craniocaudal extent, provided the axial plane — which carries the cross-sectional-area measurement used by all major grading systems — is acquired with the geometry specified in the protocol and, ideally, matched to any prior study for reproducible serial follow-up.

4.5 Fat Suppression, Contrast-Specific or Region-Specific Technical Modifiers

5. Optimisation Strategy

5.1 Artifact Reduction by Source

5.2 Protocol Efficiency and Throughput

A “premium” protocol — additional planes, oblique sequences tailored to a specific myoaponeurotic structure, and higher in-plane resolution — is justified when the clinical question is prognostically important (e.g., planning for possible surgical repair, or serial monitoring in an athlete under close rehabilitation supervision) and department time allows. A shortened protocol (the core axial and long-axis fluid-sensitive sequences plus a single T1 plane) is appropriate for the majority of routine outpatient referrals where the question is simply “confirm and grade a suspected strain.” Three-dimensional acquisition is rarely necessary for routine muscle-trauma imaging, since the diagnostic information required (oedema extent, fibre/tendon discontinuity) is well served by high-resolution 2D multiplanar imaging; 2D remains the more robust and time-efficient default for this anatomical application, with 3D reserved for specific research or reconstruction-heavy use cases rather than routine practice.

5.3 Field Strength Considerations

At 3 T, the improved signal-to-noise ratio allows either higher spatial resolution or shorter acquisition time for equivalent resolution compared with 1.5 T, and chemical-shift-based fat–water separation (Dixon) benefits from the wider frequency separation. Susceptibility and chemical-shift artefacts are more pronounced at 3 T, and SAR becomes a more binding constraint for fat-saturated turbo spin-echo sequences, occasionally requiring parameter compromises (longer TR, reduced echo-train length) that partially offset the SNR advantage. At 1.5 T, spectral fat suppression is somewhat less robust at the periphery of a large FOV, making STIR comparatively more valuable as a fallback. The practical departmental choice between field strengths for muscle-trauma imaging is usually dictated by scanner availability and coil options rather than by a strong evidence-based preference for one field strength over the other in this specific application.

6. Contrast Use Principles Specific to Muscle Trauma and Mechanical Disorders

Universal gadolinium-based contrast agent (GBCA) safety screening is addressed on the general MRI preparation page and is not repeated here; when contrast is used, the project standard of macrocyclic agents applies.

6.1 Non-Contrast Standard Protocol — Sufficient For

The large majority of muscle-trauma referrals — acute or chronic strain, contusion, DOMS, myotendinous-junction injury, non-specific muscular pain, and follow-up of a known injury during healing — are adequately and completely assessed without intravenous contrast. Fluid-sensitive fat-suppressed and T1-weighted sequences alone reliably depict oedema, fibre disruption, haematoma dating, and chronic fatty atrophy/scarring.

6.2 Gadolinium Indicated — Region-Specific Contexts

Contrast should be considered, rather than used routinely, in a small number of specific circumstances: when the imaging appearance raises concern for an abscess or infective myositis rather than a simple haematoma (rim enhancement favours the former); when a mass-like, non-oedematous lesion is identified that is not typical of simple trauma and a soft-tissue tumour cannot be confidently excluded, in which case the examination should in practice be redirected toward the dedicated soft-tissue mass protocol rather than simply adding contrast to the trauma protocol; and in selected pre-operative or diagnostically ambiguous cases where the referring surgeon specifically requests enhancement characteristics of a chronic scar or suspected recurrent lesion. STIR sequences after gadolinium administration should not be used, consistent with the project-wide rule that STIR is contraindicated after contrast administration owing to unpredictable and paradoxical suppression of the expected post-contrast signal behaviour; fat-suppressed T1-weighted sequences (spectral or Dixon-based) are the appropriate post-contrast technique.

6.3 Post-Contrast Acquisition Timing

Where contrast is used to characterise a possible abscess or inflammatory collection, early post-contrast imaging (within a few minutes of injection) is generally sufficient to demonstrate peripheral rim enhancement around a non-enhancing fluid centre; delayed acquisitions are not routinely required for this indication. Documentation of injection time and sequence timing relative to injection should be recorded, since the pattern and degree of enhancement can be time-dependent and is relevant to subsequent interpretation or comparison with prior studies.

7. Reporting Essentials

7.1 Interpretation Framework

The report should reason through the examination along several complementary axes: acute versus chronic (fresh interstitial oedema/haemorrhage versus fatty atrophy and hypointense scar); focal versus diffuse (a discrete myoconnective lesion versus a diffuse, poorly marginated “cotton-like” pattern more typical of DOMS or overuse); structural versus functional (presence or absence of macroscopic fibre or tendon discontinuity, which is the single most consistent determinant of severity and prognosis across all three major classification systems); and, where a mass-like or atypical lesion is present, traumatic/inflammatory versus neoplastic. As a practical, evidence-informed sequence for describing findings, several authors recommend reporting the status of the tendon first (gap, retraction, loss of tension), then the myoconnective junction (pennation-angle loss, fibre gap, blurring, interstitial oedema), then the thinner aponeurotic/fascial structures, and finally isolated muscular oedema and any intra- or intermuscular haematoma or fluid it is most effective to describe the signs in decreasing order of probable prognostic significance: the status of the tendon first, then the myoconnective junction, then the thinner myoconnective junctions centered on the aponeurosis and fascia, and finally isolated muscular edema and intra- or intermuscular hematomas.

7.2 Mandatory Reporting Checklist

The report should not omit: the specific muscle(s)/compartment involved and the site relative to the myotendinous junction (proximal, middle, distal third); presence or absence of fibre and/or tendon discontinuity, with an estimate of cross-sectional-area involvement and craniocaudal length if a grading system is being applied; presence, size and location of any haematoma or intermuscular fluid; comparison with any prior imaging, explicitly noting interval change or a new second lesion; technical limitations (motion, incomplete fat-suppression, coverage gaps) that could affect grading; whether contrast was used and, if so, injection-to-acquisition timing; and, where relevant, an explicit note that MRI findings should be interpreted alongside clinical examination rather than used in isolation to predict return-to-activity time, given the documented limitations of MRI-based prognostication discussed in Section 11.

7.3 Structured Reporting

Reports should follow the standard structure of indication, technique (including field strength, coil, and sequences performed), comparison, findings, impression, and limitations, with explicit critical-result communication to the referring clinician when an unexpected mass-like lesion, suspected infection, or a large expanding haematoma with vascular risk is identified.

7.4 Incidental Findings — Clinical Decision Framework

• Usually benign: small, asymptomatic old scar tissue or fatty atrophy from a remote, previously known injury; minor, focal fat-fascial variants; small, non-specific subcutaneous lipomas well outside the region of clinical interest.
• Follow-up may be needed: an asymptomatic focal signal abnormality that does not fit the clinical presentation and cannot be confidently characterised as post-traumatic; a small indeterminate lesion at the FOV margin that was not adequately characterised because it fell outside the optimised small field of view.
• Urgent or clinically important: any lesion with imaging features suspicious for a soft-tissue sarcoma (large size, heterogeneous non-fluid signal, avid or nodular enhancement, deep location); unexpected findings suggestive of infection/abscess in a patient without a corresponding clinical picture, which should prompt direct communication with the referring team.

8. MRI Technologist Pearls

8.1 Sequence Order Logic

Acquire the fluid-sensitive fat-suppressed sequence in the plane and region most likely to contain the abnormality (usually the axial or the muscle-tailored long-axis plane at the marked symptomatic site) early in the protocol, immediately after the localiser and any short overview sequence, so that a diagnostically adequate acquisition is secured before patient discomfort or motion compromises later sequences.

8.2 Positioning Tricks

Use the skin marker, not the verbal description alone, to centre the FOV; standardise and document limb rotation and, for the calf, ankle position, especially for comparative or follow-up studies; for deep or diffuse pain (adductors, proximal hamstring), consider a wider initial overview before committing to a small, tightly centred FOV.

8.3 Fast Salvage Protocol

If the patient cannot tolerate further imaging, sequence 1 alone provides a clinically usable, if incomplete, answer to the presence and rough localisation of injury; sequences 1 and 2 together are considered the practical minimum for a reportable grading.

8.4 Common Avoidable Errors

9. Quality Control Checklist

11. Evidence Gaps & Ongoing Debate

• Prognostic value of MRI findings: current evidence does not support strong, isolated prediction of return-to-play or return-to-activity time from MRI grading alone; multiple studies report weak or inconsistent correlation between specific MRI features and recovery time, and functional recovery has repeatedly been shown to precede normalisation of the MRI signal.
• Choice among classification systems: the Munich Consensus Statement, BAMIC, and FC Barcelona-Aspetar-Duke classification each have advocates and each capture partially overlapping but non-identical information; inter-reader reliability is only moderate for all three systems, and no single system has been established as clearly superior across all muscle groups and clinical settings.
• Role of diffusion-weighted imaging and quantitative T2 mapping: promising but preliminary; not yet part of routine mandatory protocols.
• Optimal timing of the first post-injury scan: largely based on expert opinion rather than high-level comparative trial evidence, although early scanning is broadly supported by observational data showing early detectability of fibre disruption and stable oedema extent in the first week.
• 2D versus 3D and Dixon versus separate STIR/T1 protocols: increasing but not yet universal departmental adoption of Dixon-based single-acquisition fat/water separation as an efficient alternative to separate sequences; comparative outcome evidence specific to muscle-trauma grading is limited.
• AI-assisted segmentation and automated measurement of oedema volume/cross-sectional area is an active area of technical development but not yet standard clinical practice for this indication.

12. Evidence-Based References

A. Guidelines / Consensus / Society Recommendations

B. Systematic Reviews / Meta-analyses / Major Educational Reviews

C. Important Prospective / Original Studies

D. Technical MRI Papers

E. Landmark Historical References

End of document — MRI Muscle in Trauma and Mechanical Disorders — Generic Standard Protocol — MRIninja Master Page v1.0 — July 2026